Drug Shortage Report for PENICILLIN G SODIUM FOR INJECTION, USP
Report ID | 15623 |
Drug Identification Number | 02220261 |
Brand name | PENICILLIN G SODIUM FOR INJECTION, USP |
Common or Proper name | PENICILLIN G SODIUM |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | PENICILLIN G |
Strength(s) | 1000000UNIT |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAMUSCULAR INTRAVENOUS |
Packaging size | 1 million unit SD vial |
ATC code | J01CE |
ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2017-07-12 |
Estimated end date | |
Actual end date | 2018-03-06 |
Shortage status | Resolved |
Updated date | 2018-03-07 |
Company comments | The product is available to all customers through all distribution channels without any volume restrictions |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2018-03-07 | English | Compare |
v6 | 2018-03-06 | French | Compare |
v5 | 2018-03-06 | English | Compare |
v4 | 2017-07-13 | English | Compare |
v3 | 2017-07-12 | French | Compare |
v2 | 2017-07-12 | English | Compare |
v1 | 2017-07-12 | English | Compare |
Showing 1 to 7 of 7